The team also found that such a shift could prevent more than 740,000 non-fatal CVD events annually and decrease new chronic kidney disease cases by nearly 7%.

Women in rural parts of the United States have experienced an increase in premature coronary artery disease (CAD) mortality, according to new findings published in the Journal of the American Heart Association.

In addition to these latest findings, a NIH-backed panel is now specifically recommending against the combination of hydroxychloroquine and azithromycin for treating COVID-19 patients.

CMS has announced that healthcare providers in communities experiencing low numbers of confirmed COVID-19 cases may be able to once again provide more in-person care unrelated to the virus.

The COVID-19 pandemic has changed patient care in countless ways, but percutaneous coronary intervention (PCI) remains the recommended standard of care for ST-segment elevation myocardial infarction (STEMI) patients.

Newer-generation drug-eluting stents (n-DES) are a more effective option for the percutaneous treatment of small-vessel coronary disease (SVCD) than drug-coated balloons (DCBs), according to new findings published in JACC: Cardiovascular Interventions.

Coala Life, a healthcare technology company based out of Sweden, has announced that physicians will now be able to use the company’s Coala Heart Monitor to conduct virtual heart and lung examinations.

One side effect of this unprecedented time is that many fourth-year medical students are being asked to join the pandemic’s front lines before they have even graduated.